ALT
Altimmune, Inc.
There isn't enough reported data to score ALT yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
ALT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Unavailable | |
| Unavailable |
ALT's revenue is currently strong, but its profitability is under pressure. There isn't enough data to rate its cash flow and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
ALT PE Valuation
ALT has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
ALT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ALT's revenue to grow, with its earnings and profitability holding steady. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
ALT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.71 | +$0.36 |
| Q2 2026 | -$0.77 | +$0.41 |
| Q1 2026 | -$0.92 | +$0.34 |
| Q4 2025 | -$1.00 | +$0.34 |
| Q3 2025 | -$1.07 | +$0.50 |
| Q2 2025 | -$1.18 | +$0.46 |
| Q1 2025 | -$1.26 | +$0.35 |
| Q4 2024 | -$1.34 | +$0.32 |
ALT is still losing money, but far less than before: $0.71 per share over the past year, against $2.41 at its worst in early 2022.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over ALT on earnings quality, reporting a profit while its opponent remains loss making.
ALT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $26K | +420% |
| Q3 2025 | $5K | 0% |
| Q2 2025 | $5K | 0% |
| Q1 2025 | $5K | 0% |
| Q4 2024 | $5K | -86% |
| Q3 2024 | $5K | -99% |
| Q2 2024 | $5K | -17% |
| Q1 2024 | $5K | -76% |
ALT has the stronger quarterly revenue trend. Revenue is up 420% for ALT versus down 0.4% for UNH.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -111127% | +386193 points |
| Q3 2025 | -417180% | +78160 points |
| Q2 2025 | -458440% | +76460 points |
| Q1 2025 | -436300% | +99580 points |
| Q4 2024 | -497320% | -406447 points |
| Q3 2024 | -495340% | -489114 points |
| Q2 2024 | -534900% | -234783 points |
| Q1 2024 | -535880% | -432266 points |
ALT's operating margin was −111127% last quarter, up 386193 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
ALT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$37.8M | -$25.9M |
| Q1 2026 | -$21M | -$4.1M |
| Q4 2023 | -$16.5M | +$811K |
| Q3 2023 | -$20.5M | -$5.4M |
| Q2 2023 | -$19.4M | -$2.7M |
| Q1 2023 | -$19.5M | -$5.9M |
| Q4 2022 | -$17.3M | +$4.8M |
| Q3 2022 | -$15.1M | +$2.7M |
ALT has burned cash in almost every quarter: −$102M over the past year, against −$66M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over ALT on cash generation, producing positive trailing cash flow while its opponent burns cash.
ALT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +11% | +19.8M shares |
| 1 year | +152% | +124M shares |
| 3 years | +310% | +155M shares |
| 5 years | +427% | +166M shares |
| Available history | +1464% | +192M shares |
ALT has 205M diluted shares, up 152% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over ALT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
ALT Net Leverage
ALT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
ALT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.5 | Oversold |
| Stochastic | 4.7 | Oversold |
ALT's weekly RSI is 27 (oversold) and its Stochastic is 5 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
ALT PE vs Healthcare Sector
ALT has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
ALT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.31 | 30% below |
| 20 week MA | $2.77 | 42% below |
| 50 week MA | $3.33 | 52% below |
| 100 week MA | $4.23 | 62% below |
| 200 week MA | $5.48 | 71% below |
ALT is in a downtrend: it's below all five of its weekly moving averages, and 71% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over ALT on trend strength, trading above more of its moving averages.
ALT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.80 | $11.5 | +536% |
| 2021 | $11.5 | $9.20 | -20% |
| 2022 | $9.20 | $15.3 | +67% |
| 2023 | $15.3 | $11.3 | -27% |
| 2024 | $11.3 | $7.67 | -32% |
| 2025 | $7.67 | $3.86 | -50% |
| 2026 YTD | $3.86 | $1.61 | -58% |
ALT has finished three years in a row lower, and it's down 58% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over ALT on returns for 2026, with the stronger performance.